Evaluation of the new marker interleukin - 33 in Iraqi female patients with hyperthyroidism.

Background: Hyperthyroidism refers to overactive of thyroid gland leading to excessive synthesis of thyroid hormones and accelerated metabolism in the peripheral tissue. Objective: The aim of this study is to evaluate a new member of the IL-1 super family of cytokines interleukin-33(IL-33) levels in serum .in order to evaluate its utility as clinical bio marker of autoimmune disease (i.e. hyperthyroidism) Methods: The present study was conducted on 30 patients from the Iraqi female patients with hyperthyroidism attending Baghdad teaching hospital, in addition to 30 healthy controls. All subjects were (35-65) years old. Parameters measured in the sera of patients and healthy groups, were interleukin -33 (IL-33), Thyroxin (T4), Thyroxin (T3) and Thyroid stimulating hormone TSH. Results: A new member of super family cytokines Interleukin -33 was determined in hyperthyroidism, female patients. Higher significant elevation was found when compared with healthy control. Conclusion: From this study a conclusion was drawn, that evaluation of concentration of a new super family cytokines IL-33 could consider as a clinical biomarkers in hyperthyroidism female patients. This finding may indicate that autoimmune disease like hyperthyroidism might influence cytokine like interleukin -33 production in these patients Key word: Hyperthyroidism, Interlukin-33, Thyroxin, Thyroid stimulating hormone. Original Article

[1]  D. Ye,et al.  IL-33 , 2012, Journal of Investigative Medicine.

[2]  E. Martı́n-Mola,et al.  Frequency of Th17 CD4+ T Cells in Early Rheumatoid Arthritis: A Marker of Anti-CCP Seropositivity , 2012, PloS one.

[3]  J. Devière,et al.  The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice. , 2012, The American journal of pathology.

[4]  M. Steinhoff,et al.  IL-33: a novel danger signal system in atopic dermatitis. , 2012, The Journal of investigative dermatology.

[5]  A. Sachan,et al.  Bone disease in thyrotoxicosis , 2012, The Indian journal of medical research.

[6]  N. Viner,et al.  Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects , 2011, Arthritis research & therapy.

[7]  Inbal Goshen,et al.  Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling , 2011, Brain, Behavior, and Immunity.

[8]  Xia Li,et al.  IL-33: a promising therapeutic target for rheumatoid arthritis? , 2011, Expert opinion on therapeutic targets.

[9]  Ashley M. Miller,et al.  IL-33 Reduces Macrophage Foam Cell Formation , 2010, The Journal of Immunology.

[10]  I. McInnes,et al.  The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases , 2009, Arthritis research & therapy.

[11]  Dirk E. Smith,et al.  Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. , 2009, Arthritis and rheumatism.

[12]  V. S. Wong Kochar’s Clinical Medicine for Students , 2009 .

[13]  Richard T. Lee,et al.  The IL-33/ST2 pathway: therapeutic target and novel biomarker , 2008, Nature Reviews Drug Discovery.